Announced Fri, 26 Jun · 09:50 IST
Trading Window Closure from July 1 2026 Pending Q1 FY27 Results
Compliance View source PDF
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.3%1-day move
₹3191.00
prior close
₹3180.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.5+1.4+1.7+2.4+7.3+4.8+4.7+4.6+5.8+2.9+8.6———
Up moveDown movePending
AI summary
Ajanta Pharma has informed exchanges that the trading window for dealing in its securities will be closed from Wednesday, July 1, 2026 till 48 hours after the declaration of financial results for Q1 FY27 (quarter ended June 30, 2026). This is a routine compliance filing under SEBI insider trading regulations and the company's insider code of conduct. Signed by Gaurang Shah, Sr VP Legal and Company Secretary.
Likely market impact
Routine compliance filing. Insiders barred from trading till Q1 FY27 results are declared plus 48 hours. No direct impact on retail shareholders.